Scientists use Salmonella to fight cancer in first human trials

December 07, 1999

(NEW HAVEN) -- A genetically engineered strain of the bacteria Salmonella has been administered to the first cancer patients enrolled in a Phase I intratumoral clinical trial. The patients were initially monitored in the hospital and subsequently discharged.

The concept, developed by Yale Cancer Center researchers and licensed to Vion Pharmaceuticals in New Haven, Conn., involves the use of engineered strains of the common Salmonella bacterium, the same bacterium that, in its unaltered or wild type form, can cause food poisoning and septic shock. The altered Salmonella, stripped of its pathogenicity, has been shown to target solid tumors and inhibit their growth in laboratory animals.

The key is that the safe versions are still able to target solid tumors in laboratory animals, much like the wild type parent, while at the same time have little or no adverse effects. "We have shown that we can significantly prolong the life of mice with melanoma by injecting them with our attenuated bacteria," said John M. Pawelek, Ph.D., senior research scientist in dermatology and a lecturer in pharmacology at the Yale University School of Medicine. "These preliminary results with animals are encouraging. We would now like to see the same outcome in people."

Collaborating with Pawelek on this novel approach to fighting cancer are K. Brooks Low, Ph.D., a bacterial geneticist and professor of research in therapeutic radiology at Yale, and former Yale colleague David Bermudes, Ph.D., now a senior scientist working on the Salmonella project at Vion.

Potential safety and efficacy will continue to be monitored according to the protocol. The study is designed to evaluate the safety, potential efficacy and optimum biological dose of the bacterial vector for patients with either cutaneous or subcutaneous solid tumors. Patient accrual for the trial is continuing.
The Yale Cancer Center is one of a select network of comprehensive cancer centers in the country designated by the National Cancer Institute and the only one in Southern New England. Bringing together the resources of Yale-New Haven Hospital and the Yale University School of Medicine, its mission encompasses patient care, research, cancer prevention and control, community outreach and education.

Yale University

Related Bacterium Articles from Brightsurf:

Root bacterium to fight Alzheimer's
A bacterium found among the soil close to roots of ginseng plants could provide a new approach for the treatment of Alzheimer's.

Tuberculosis bacterium uses sluice to import vitamins
A transport protein that is used by the human pathogen Mycobacterium tuberculosis to import vitamin B12 turns out to be very different from other transport proteins.

Bacterium makes complex loops
A scientific team from the Biosciences and Biotechnology Institute of Aix-Marseille in Saint-Paul lez Durance, in collaboration with researchers from the Max Planck Institute of Colloids and Interfaces in Potsdam and the University of Göttingen, determined the trajectory and swimming speed of the magnetotactic bacterium Magnetococcus marinus, known to move rapidly.

Researchers show how opportunistic bacterium defeats competitors
The researchers discovered that Stenotrophomonas maltophilia uses a secretion system that produces a cocktail of toxins and injects them into other microorganisms with which it competes for space and food.

Genetic typing of a bacterium with biotechnological potential
Researchers at Kanazawa University describe in Scientific Reports the genetic typing of the bacterium Pseudomonas putida.

How the strep bacterium hides from the immune system
A bacterial pathogen that causes strep throat and other illnesses cloaks itself in fragments of red blood cells to evade detection by the host immune system, according to a study publishing December 3 in the journal Cell Reports.

The cholera bacterium can steal up to 150 genes in one go
EPFL scientists have discovered that predatory bacteria like the cholera pathogen can steal up to 150 genes in one go from their neighbors.

Exploiting green tides thanks to a marine bacterium
Ulvan is the principal component of Ulva or 'sea lettuce' which causes algal blooms (green tides).

The cholera bacterium's 3-in-1 toolkit for life in the ocean
The cholera bacterium uses a grappling hook-like appendage to take up DNA, bind to nutritious surfaces and recognize 'family' members, EPFL scientists have found.

Excellent catering: How a bacterium feeds an entire flatworm
In the sandy bottom of warm coastal waters lives Paracatenula -- a small worm that has neither mouth, nor gut.

Read More: Bacterium News and Bacterium Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to